Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Observe Medical ASA ( (DE:OM50) ) has provided an announcement.
Observe Medical has published its Annual Report for 2024, which includes adjustments following discussions with the Norwegian Financial Supervisory Authority. Key changes include a goodwill write-down of NOK 67.1 million and additional expenses related to development costs and the Convatec transaction. The report highlights a qualified opinion from auditors regarding impairment assessments and notes a material uncertainty concerning the company’s going concern assumption.
More about Observe Medical ASA
Observe Medical is a Nordic medtech company headquartered in Oslo, Norway, that develops, markets, and sells innovative medical technology products globally. The company focuses on improving patient welfare, clinical data accuracy, and health economics through its portfolio, which includes urine measurement and ultrasound products. It aims to drive growth through sales expertise, commercialization, targeted mergers and acquisitions, and distribution partnerships.
Average Trading Volume: 105,821
Current Market Cap: NOK22.15M
For detailed information about OM50 stock, go to TipRanks’ Stock Analysis page.